A comparison of oral controlled-release morphine and oxycodone with transdermal formulations of buprenorphine and fentanyl in the treatment of severe pain in cancer patients
Krzysztof Nosek,1 Wojciech Leppert,2,3 Hanna Nosek,4 Jerzy Wordliczek,5 Dariusz Onichimowski6 1Non–public Saint Lazarius Health Care Unit, Biskupiec, 2Chair and Department of Palliative Medicine, Poznan University of Medical Sciences, Poznań, 3Department of Quality of life Research, Gdańs...
Main Authors: | Nosek K, Leppert W, Nosek H, Wordliczek J, Onichimowski D |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-08-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/a-comparison-of-oral-controlled-release-morphine-and-oxycodone-with-tr-peer-reviewed-article-DDDT |
Similar Items
-
Transdermal and Topical Drug Administration in the Treatment of Pain
by: Wojciech Leppert, et al.
Published: (2018-03-01) -
Fentanyl but Not Morphine or Buprenorphine Improves the Severity of Necrotizing Acute Pancreatitis in Rats
by: Emese Réka Bálint, et al.
Published: (2022-01-01) -
The use of transdermal fentanyl in the treatment of cancer pain
by: Radovanović Dragana, et al.
Published: (2002-01-01) -
Tolerability of buprenorphine transdermal system in nursing home patients with advanced dementia: a randomized, placebo-controlled trial (DEP.PAIN.DEM)
by: Erdal A, et al.
Published: (2018-05-01) -
Efficacy and Safety of Topical Morphine: A Narrative Review
by: Krzysztof Nosek, et al.
Published: (2022-07-01)